Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis

Paolo Poggio1, Rachana Sainger, Emanuela Branchetti

  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Aortic valve sclerosis (AVSc) can be induced to show osteogenic markers. Combining BMP4 and mechanical stimulation drives valve interstitial cells (VICs) toward a calcified phenotype.

Area of Science:

  • Cardiovascular Biology
  • Biomaterials Science
  • Cellular Biology

Background:

  • Aortic valve sclerosis (AVSc) is a precursor to calcific aortic valve stenosis (AVS), affecting 25-30% of individuals over 65.
  • AVSc involves leaflet thickening but is often asymptomatic due to minimal impact on valve mechanics.
  • The pathogenesis of AVSc remains understudied, particularly using human tissue samples.

Purpose of the Study:

  • To investigate the role of BMP4 in the osteogenic transdifferentiation of human valve interstitial cells (VICs) in AVSc.
  • To explore the combined effects of BMP4 and mechanical stimulation on VICs derived from AVSc specimens.
  • To elucidate the mechanisms underlying the progression from AVSc to more advanced stages of aortic stenosis.

Main Methods:

  • Human aortic valve specimens from 60 patients (AVS, AVSc, and controls) were analyzed.
  • In vitro and ex vivo experiments utilized cell culture and a Tissue Engineering (TE) Aortic Valve model.
  • BMP4 and its antagonist Noggin were used to modulate VIC activation and biomineralization, alongside mechanical stimulation.

Main Results:

  • Non-calcified AVSc leaflets, when treated with BMP4 and mechanical stimulation, expressed osteogenic and biomineralization markers.
  • BMP4 alone did not induce osteogenic transdifferentiation; however, combined with mechanical stretch, it activated VICs towards a late calcified phenotype.
  • The BMP4 antagonist Noggin effectively reduced VIC activation and biomineralization, highlighting BMP4's crucial role.

Conclusions:

  • This study provides the first evidence using AVSc specimens that human sclerotic aortic valves can be induced to exhibit an osteogenic phenotype.
  • The findings suggest that BMP4 signaling, in conjunction with mechanical forces, plays a significant role in the progression of AVSc towards severe aortic stenosis.
  • These insights could inform future therapeutic strategies targeting AVSc and AVS.
Abstract

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...